KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Change in Account Payables (2021 - 2025)

Historic Change in Account Payables for LifeMD (LFMD) over the last 5 years, with Q3 2025 value amounting to -$4.7 million.

  • LifeMD's Change in Account Payables fell 68083.89% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 4081.51%. This contributed to the annual value of $4.9 million for FY2024, which is 40350.89% up from last year.
  • As of Q3 2025, LifeMD's Change in Account Payables stood at -$4.7 million, which was down 68083.89% from $8.6 million recorded in Q2 2025.
  • LifeMD's 5-year Change in Account Payables high stood at $8.6 million for Q2 2025, and its period low was -$4.7 million during Q3 2025.
  • Its 5-year average for Change in Account Payables is $530451.2, with a median of $259180.0 in 2022.
  • In the last 5 years, LifeMD's Change in Account Payables surged by 188780.9% in 2022 and then plummeted by 68083.89% in 2025.
  • LifeMD's Change in Account Payables (Quarter) stood at -$2.4 million in 2021, then soared by 76.07% to -$576066.0 in 2022, then surged by 351.27% to $1.4 million in 2023, then crashed by 90.19% to $142015.0 in 2024, then tumbled by 3436.36% to -$4.7 million in 2025.
  • Its last three reported values are -$4.7 million in Q3 2025, $8.6 million for Q2 2025, and -$330456.0 during Q1 2025.